rs121918457
|
|
|
0.780 |
GeneticVariation |
BEFREE |
Furthermore, we show that the recurrent LS-causing Y279C and T468M amino acid substitutions engender loss of SHP-2 catalytic activity, identifying a previously unrecognized behavior for this class of missense PTPN11 mutations.
|
16358218 |
2006 |
rs121918457
|
|
T |
0.780 |
CausalMutation |
CLINVAR |
[LEOPARD syndrome].
|
19174044 |
2009 |
rs121918457
|
|
T |
0.780 |
CausalMutation |
CLINVAR |
PTPN11-associated mutations in the heart: has LEOPARD changed Its RASpots?
|
22681964 |
2011 |
rs121918457
|
|
T |
0.780 |
CausalMutation |
CLINVAR |
PTPN11 mutation manifesting as LEOPARD syndrome associated with hypertrophic plexi and neuropathic pain.
|
25884655 |
2015 |
rs121918457
|
|
T |
0.780 |
CausalMutation |
CLINVAR |
ClinGen's RASopathy Expert Panel consensus methods for variant interpretation.
|
29493581 |
2018 |
rs121918457
|
|
|
0.780 |
GeneticVariation |
BEFREE |
Direct sequencing of the patients' genomic DNA revealed that all three had a consistent missense mutation [c.1403C > T (p.T468M)] in the PTPN11 gene, confirming LEOPARD syndrome with an atypical phenotype.
|
20883402 |
2010 |
rs121918457
|
|
T |
0.780 |
CausalMutation |
CLINVAR |
Multiple granular cell tumors are an associated feature of LEOPARD syndrome caused by mutation in PTPN11.
|
19054014 |
2009 |
rs121918457
|
|
|
0.780 |
GeneticVariation |
BEFREE |
The present study reports a young child diagnosed with LS via identification of a common p.Thr468Met mutation in PTPN11.
|
27484170 |
2016 |
rs121918457
|
|
|
0.780 |
GeneticVariation |
BEFREE |
LEOPARD syndrome (PTPN11, T468M) in three boys fulfilling neurofibromatosis type 1 clinical criteria.
|
21365175 |
2011 |
rs121918457
|
|
T |
0.780 |
CausalMutation |
CLINVAR |
Diverse driving forces underlie the invariant occurrence of the T42A, E139D, I282V and T468M SHP2 amino acid substitutions causing Noonan and LEOPARD syndromes.
|
18372317 |
2008 |
rs121918457
|
|
T |
0.780 |
CausalMutation |
CLINVAR |
PTPN11 mutations in LEOPARD syndrome: report of four cases in Taiwan.
|
19864201 |
2009 |
rs121918457
|
|
|
0.780 |
GeneticVariation |
BEFREE |
Diverse driving forces underlie the invariant occurrence of the T42A, E139D, I282V and T468M SHP2 amino acid substitutions causing Noonan and LEOPARD syndromes.
|
18372317 |
2008 |
rs121918457
|
|
T |
0.780 |
CausalMutation |
CLINVAR |
Molecular basis of gain-of-function LEOPARD syndrome-associated SHP2 mutations.
|
24935154 |
2014 |
rs121918457
|
|
T |
0.780 |
CausalMutation |
CLINVAR |
Cognitive profile of disorders associated with dysregulation of the RAS/MAPK signaling cascade.
|
19133693 |
2009 |
rs121918457
|
|
T |
0.780 |
CausalMutation |
CLINVAR |
Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene.
|
12058348 |
2002 |
rs121918457
|
|
T |
0.780 |
CausalMutation |
CLINVAR |
Here we present a patient with severe, progressive neonatal HCM, elevated urinary catecholamine metabolites, and dysmorphic features in whom we identified a known LEOPARD syndrome-associated PTPN11 mutation (c.1403 C > T; p.T468M) and a novel, potentially pathogenic missense SOS1 variant (c.1018 C > T; p.P340S) replacing a rigid nonpolar imino acid with a polar amino acid at a highly conserved position.
|
22585553 |
2012 |
rs121918457
|
|
|
0.780 |
GeneticVariation |
BEFREE |
We report a patient with Noonan syndrome with multiple lentigines (NSML) due to a PTPN11 (p.Thr468Met) mutation associated with hypertrophic neuropathy of lumbar plexus in an adult woman, initially referred for neuropathic pain.
|
26952712 |
2016 |
rs121918457
|
|
T |
0.780 |
CausalMutation |
CLINVAR |
Phosphatase-defective LEOPARD syndrome mutations in PTPN11 gene have gain-of-function effects during Drosophila development.
|
18849586 |
2009 |
rs121918457
|
|
T |
0.780 |
CausalMutation |
CLINVAR |
PTPN11 mutations in patients with LEOPARD syndrome: a French multicentric experience.
|
15520399 |
2004 |
rs121918457
|
|
T |
0.780 |
CausalMutation |
CLINVAR |
PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects.
|
16377799 |
2006 |
rs121918457
|
|
T |
0.780 |
CausalMutation |
CLINVAR |
Furthermore, we show that the recurrent LS-causing Y279C and T468M amino acid substitutions engender loss of SHP-2 catalytic activity, identifying a previously unrecognized behavior for this class of missense PTPN11 mutations.
|
16358218 |
2006 |
rs121918457
|
|
T |
0.780 |
CausalMutation |
CLINVAR |
We report on a family with LEOPARD syndrome which was molecularly proven (p.Thr468Met in PTPN11) in a father and his adult son.
|
17935252 |
2007 |
rs121918457
|
|
|
0.780 |
GeneticVariation |
BEFREE |
Here we present a patient with severe, progressive neonatal HCM, elevated urinary catecholamine metabolites, and dysmorphic features in whom we identified a known LEOPARD syndrome-associated PTPN11 mutation (c.1403 C > T; p.T468M) and a novel, potentially pathogenic missense SOS1 variant (c.1018 C > T; p.P340S) replacing a rigid nonpolar imino acid with a polar amino acid at a highly conserved position.
|
22585553 |
2012 |
rs121918457
|
|
T |
0.780 |
CausalMutation |
CLINVAR |
A new examination of the patient and his similarly affected father, who was initially referred as healthy, led us to suspect LEOPARD syndrome, The diagnosis was then confirmed by the occurrence in both patients of a heterozygous mutation c.1403 C > T, p.(Thr468Met), of PTPN11.
|
24767283 |
2014 |
rs121918457
|
|
T |
0.780 |
CausalMutation |
CLINVAR |
Pediatric cardiomyopathy: importance of genetic and metabolic evaluation.
|
22555271 |
2012 |